Neurology Department, Lille University Hospital, Hôpital Roger Salengro, Lille Cedex, France.
J Neurol. 2012 Jul;259(7):1461-7. doi: 10.1007/s00415-011-6359-4. Epub 2011 Dec 20.
Despite increasing life expectancy, few data exist on the outcome of elderly stroke patients treated with IV thrombolysis. We analyzed the prospectively collected data from the Lille University Hospital stroke unit on patients treated with IV rt-PA within 4.5 h, comparing patients ≥80 years to younger ones. We considered the following outcomes: neurological improvement at the acute phase (NIHSS 0 or 1 at 24 h, or if the difference between NIHSS at 24 h and at baseline was ≥4), occurrence of intracerebral haemorrhage, mortality and functional outcome in survivors (favourable if mRS ≤2 or equal to pre-stroke score) at 3 months. Predictors of vital and functional outcome were determined using logistic regression analysis. Four hundred patients were treated with IV rt-PA, 98 (25%) being ≥80 years. The proportion of patients with neurological improvement at the acute phase (31 vs. 40%, OR 0.7, 95%CI 0.4-1.2), and with ICH (19 vs. 21%, OR 0.9, 95%CI 0.5-1.7) was similar among older and younger patients. At 3 months, 35% of patients ≥80 years had died; 52% of survivors had favourable functional outcome. Using multivariate analysis, age ≥80 years was an independent predictor of death (3.4; 95%CI 1.6-7.3), and of reduced likelihood of favourable functional outcome in survivors (OR 0.3; 95%CI 0.2-0.7) at 3 months. Although outcome at 3 months is worse for older patients than for their younger counterparts, our results are encouraging with a similar proportion of patients with early neurological improvement and with ICH in old and young patients and about half of the survivors having a favourable functional outcome in patients ≥80 years.
尽管预期寿命有所增加,但很少有数据涉及接受 IV 溶栓治疗的老年卒中患者的结局。我们分析了里尔大学医院卒中病房前瞻性收集的 4.5 小时内接受 IV rt-PA 治疗的患者数据,比较了年龄≥80 岁的患者与年轻患者的情况。我们考虑了以下结局:急性期神经功能改善(24 小时 NIHSS 评分为 0 或 1,或 24 小时 NIHSS 评分与基线相比增加≥4 分)、颅内出血、死亡率和幸存者 3 个月时的功能结局(mRS≤2 分或等于基线前评分)。使用逻辑回归分析确定了生命和功能结局的预测因素。400 名患者接受了 IV rt-PA 治疗,其中 98 名(25%)年龄≥80 岁。急性期神经功能改善(31%比 40%,OR0.7,95%CI0.4-1.2)和颅内出血(19%比 21%,OR0.9,95%CI0.5-1.7)的患者比例在年龄较大和较小的患者之间相似。3 个月时,≥80 岁的患者中有 35%死亡;52%的幸存者功能结局良好。使用多变量分析,年龄≥80 岁是死亡的独立预测因素(3.4;95%CI1.6-7.3),也是幸存者功能结局较差的独立预测因素(OR0.3;95%CI0.2-0.7)。尽管与年轻患者相比,老年患者 3 个月时的结局较差,但我们的结果令人鼓舞,老年和年轻患者早期神经功能改善和颅内出血的比例相似,约一半的幸存者在≥80 岁的患者中功能结局良好。